"Most women with hereditary risk would like an alternative to prophylacticmastectomy, " says Tom Frank , Myriad's medical director and vice president of medical services.
In a global study conducted by Dr. Steven Narod, senior scientist at Women's College Research Institute in Toronto, the United States had the highest rate of prophylacticmastectomy in BRCA1 and BRCA2 mutation carriers.